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oscillations arising through activation of the metabotropic glutamate receptor mGluR5a expressed in Chinese hamster ovary cells and find that these oscillations are largely insensitive to agonist concentration. Using an inducible receptor expression system and a non-competitive antagonist, in conjunction with the translocation of eGFP-PH PLC␦ to monitor inositol 1,4,5-trisphosphate (InsP 3 ) oscillations in single cells, we show that mGluR5a density determines the frequency of these oscillations. The predominant underlying mechanism resulted from a negative feedback loop whereby protein kinase C (PKC) inhibited InsP 3 generation. Down-regulation of PKC by prolonged exposure to phorbol ester revealed a second form of Ca i ) 1 oscillations is a common event after G protein-coupled receptor (GPCR) activation (reviewed in Refs. [1] [2] [3] [4] , and in many instances the frequency rather than the spike amplitude or duration primarily defines the physiological response (5, 6) . Identifying what modulates the frequency is thus crucial to determining how GPCRs can differentially influence diverse cellular functions. Intuitively, the extent of GPCR activation and consequently the stimulus strength would determine the final frequency. However, for the Group I metabotropic glutamate receptor, mGluR5a, we have found that this is not always the case and, dependent upon what mechanism generates the oscillations, two distinct parameters can define the frequency.
Although the intracellular processes that underlie different patterns of Ca 2ϩ i signal are complex (2-4, 7), the proposed mechanisms for Ca 2ϩ i oscillations involving InsP 3 production following GPCR-mediated activation of phospholipase C (PLC) can generally be classified into two categories (2, 8, 9) . The best characterized occur at low levels of InsP 3 (2) (3) (4) 10) . This manifests itself as oscillations involving Ca 2ϩ -induced Ca 2ϩ waves. The second type of oscillation, which we termed dynamic uncoupling or desensitization (9) , broadly involves feedback inhibition of PLC activity to generate oscillations in InsP 3 production that then drive the subsequent Ca 2ϩ i oscillations (8) . The mechanisms currently proposed to mediate this process involve either protein kinase C (PKC) feedback inhibition (9, 11) or oscillations in the activity of regulator of G protein signaling (RGS) proteins (12) .
The study of the Group I metabotropic glutamate receptor, mGluR5, has provided strong evidence for dynamic feedback inhibition involving PKC (13) (14) (15) . This receptor induces oscillatory patterns of Ca 2ϩ i due to cyclical desensitization/resensitization through PKC phosphorylation of a single site present in the C-terminal tail of the receptor (13, 14) . The direct involvement of classic Ca 2ϩ -sensitive PKCs in generating repetitive PLC inhibition has recently been established by studies that showed PKC-dependent InsP 3 oscillations (9) and oscillatory PKC translocation (11) . Surprisingly, however, we have now found that altering agonist concentration, or using agonists with different efficacies had relatively little effect on the frequency of these oscillations, mirroring earlier findings on PKC-dependent muscarinic receptor-induced Ca 2ϩ oscillations in lacrimal acinar cells (16) . Physiologically it seems unlikely that a GPCR would lose control over such a significant attribute of oscillatory responses, i.e. the ability to modulate the frequency, and it is probable that factors other than agonist concentration are involved. mGluR5-mediated Ca 2ϩ i oscillations are driven by PKC phosphorylation of the receptor (13, 14) , therefore, this led us to propose that receptor expression levels might influence the frequency.
We have addressed this question directly by using two separate approaches: an inducible mGluR5a expression system and titrated amounts of a non-competitive antagonist, and show that receptor density is indeed critical in defining oscillation frequency. Importantly, we also observed agonist concentration-sensitive Ca 2ϩ i oscillations in the absence of PKCfeedback inhibition and InsP 3 oscillations. This suggests that the extent of PKC regulation determines which of two distinct mechanisms generates the InsP 3 -induced Ca 2ϩ i oscillations. We propose a "sliding-scale" model in which the different modes of Ca 2ϩ signaling are envisaged as a continuum arising from the same basic machinery but dependent upon the degree of feedback control. These two mechanisms use different methods (i.e. agonist versus receptor concentration) to modulate the Ca 2ϩ i signal, and so these observations may have important implications for the regulation of mGluR5 function and its role in adaptive responses in the CNS.
EXPERIMENTAL PROCEDURES
Materials-Vectors containing the fusion constructs between eGFP and the PH domain of PLC␦1, and eGFP and PKC␥ were a gift from Professor T. Meyer (Stanford University). Human mGluR5a cDNA was provided by GlaxoSmithKline (Verona) and the LacSwitch II system purchased from Stratagene. The open reading frame of rat InsP 3 3-kinase A was amplified from a hippocampal culture cDNA library using the PCR conditions of Woodring and Garrison (17) . The insert was cloned into the HindIII and BamHI sites of pEGFPC1 (CLONTECH) as described in Ref. 18 and then fully sequenced. This construct was used as a PCR template to produce a truncated version of the InsP 3 kinase open reading frame that lacked the first 198 nucleotides, which code for the N-terminal F-actin binding site (18) . This was cloned into the DsRed2C1 vector (CLONTECH) to produce cytosolic DsRed-InsP 3 3-kinase (amino acids 66 -459). The kinase-dead version of this construct contains two mutations (D260A and K262A) in the InsP 3 binding site (19) and was produced using the QuikChange mutagenesis kit (Stratagene) using the following primers (mutated codons are underlined, and mutated bases are in boldface): sense, 5Ј-gaccttgcgtgcttgcctgcgcgatgggtgtcag-3Ј; antisense, 5Ј-gttctgacacccatcgcg-caggcaagcacgcaag-3Ј. The mutations were confirmed by sequencing.
Polyclonal anti-mGluR5a antibody was from Upstate Biochemicals. Radiochemicals were from Amersham Biosciences UK. Quisqualate was from Tocris-Cookson (Bristol, UK). Fura-2AM was from Molecular Probes (Cambridge, UK) and Dowex anion exchange resin AG1-X8 (200 -400 mesh, formate form) from Bio-Rad (Watford, UK). FuGENE 6.0 was from Roche Biochemicals, and materials for cell culture were supplied by Invitrogen (Paisley, UK). Standard chemicals and biochemicals were from Sigma (Poole, UK) unless otherwise indicated.
Cell Culture-Human mGluR5a cDNA was cloned into the LacSwitch operator plasmid pOPRSIV-MCS and used to stably transfect Chinese hamster ovary cells previously transfected with the LacSwitch repressor plasmid (pCMVLac) (20) . Stable clones were incubated with IPTG (1 mM) overnight and inducible mGluR5a expression determined by Western blotting using anti-mGluR5 antibody (1:1000, 4 h at room temperature) using previously described techniques (20) . Clones showing minimal receptor expression in the absence of IPTG with robust inducible expression were further tested for quisqualate-induced [ 3 H]InsPs accumulation (see below) to identify the optimal CHO-lacmGlu5a cell-line. For these studies enhanced receptor expression was achieved by preincubation with IPTG in the presence of 10 mM butyric acid for greater than 20 h (21). To minimize the exposure to glutamate, CHO-lac-mGlu5a cells were grown in Dulbecco's modified Eagle's medium with Glutamax containing 10% fetal calf serum, proline (44 mg/ ml), amphotericin B (2.5 g/ml), penicillin (10 5 units/liter), streptomycin (100 g/ml), and 300 g/ml G418. During the induction of receptor expression, cells were maintained in essentially the same culture medium except for the substitution of 10% dialyzed serum and the absence of G418.
[ 3 H]Quisqualate Binding-Saturation binding experiments were performed using [
3 H]quisqualate to compare mGluR5a receptor densities in CHO-lac-mGlu5a cell membranes, following induction using 10 and 100 M IPTG using methods as described previously (22) . In brief, membranes (100 g of protein) were incubated in 20 mM HEPES, 2 mM MgCl 2 , pH 7.4, containing glutamic-pyruvic transaminase (1 unit ml Ϫ1 ) and pyruvate (5 mM) in a final volume of 0.5 ml for 45 (23) .
Imaging Single Cell InsP 3 -The real-time visualization of changes in the subcellular distribution of eGFP-PH PLC␦ were performed using an Ultraview LCI confocal system (PerkinElmer Life Sciences) connected to an Olympus IX-70 microscope with an oil immersion objective (ϫ60). Cells were seeded onto 22-mm coverslips for 8 h and then transiently transfected with 1 g of eGFP-PH PLC␦ plasmid DNA using FuGENE 6 (1:3 ratio). Where indicated, cells were similarly transfected with PKC␥-eGFP and on occasion co-transfected with DsRed2-tagged InsP 3 3-kinase (1 g). After ϳ20 h the medium was replaced with fresh culture medium containing the required [IPTG] , and the cells were incubated for a further 18 -20 h. The cells were then washed for at least 30 min in KHB before being placed in a custom-built coverslip chamber on the microscope. The chamber was maintained at 37°C using a Peltier unit, and cells were perfused with KHB (5 ml/min) using a Gilson Minipuls 2 pump. Confocal images were captured by excitation at 488 nm and accumulating the emitted light for ϳ1-s exposure of the digital charge-coupled device camera. Drugs were applied through the perfusion line for the indicated times (generally for 3-4 min). Changes in cytosolic eGFP fluorescence were quantified by taking the ratio of the average signal from a region in the cytosol to the basal level in the same region after subtracting the background reading. For experiments involving dual expression of eGFP-and DsRed2-tagged proteins, cells were excited sequentially at 488 and 568 nm, respectively. Ca 2ϩ i Imaging and Dual Imaging-Changes in the levels of [Ca 2ϩ ] i were followed in Fura-2AM-loaded cells using a Nikon Diaphot inverted epifluorescence microscope with an oil immersion objective (ϫ40) and a SpectraMASTER II module (PerkinElmer Life Sciences). Cells were grown on 22-mm coverslips and, where stated, transfected for dual imaging as above. For measurement of Ca 2ϩ i , Fura-2AM dissolved in 20% pluronic acid was added to 2 ml of KHB (5 M final concentration), and cells were incubated at room temperature for 1-1.5 h. After washing for at least 30 min cells were transferred to the coverslip holder and mounted on the microscope stage. Sequential images were then captured at wavelengths above 510 nm after excitation at 340 and 380 nm for Ca 2ϩ i imaging alone and additionally at 488 nm for eGFP-PH PLC␦ and Ca 2ϩ i imaging. The Ca 2ϩ i signal was expressed as the 340:380 ratio, and changes in cytosolic eGFP fluorescence were as described above.
Data Analysis-Curve fitting of concentration-dependent data was performed using Prism 3.0 (GraphPad Software Inc., San Diego, CA), and half-maximal (EC 50 ) values were determined using the non-linear regression analysis available in the software. Statistical comparisons were made using Student's paired or unpaired t test and a p value of Ͻ0.05 was considered significant.
RESULTS
Inducible Expression of mGluR5a-The LacSwitch II system (Stratagene) was used to establish heterologous inducible mGluR5a expression in Chinese hamster ovary cells (Fig. 1 ) in a manner similar to that used previously for mGluR1␣ (20, 21) . In this system transgene expression is under the control of a Rous sarcoma virus promoter containing three binding sites for the Lac repressor protein. The extent of transcription of the gene of interest can be simply modulated, within each individual cell (21) , by varying the concentration of the allosteric inhibitor of the Lac repressor protein isopropyl-␤-D-thiogalactoside (IPTG) (20, 23) . The optimal CHO-lac-mGlu5a clone chosen expressed no detectable receptor protein in the absence of IPTG, indicating near total repression of transcription (Fig.  1A) . When the cells were incubated for 20 h with 100 M IPTG, significant mGluR5a expression was observed, and this could be titrated by using different concentrations of IPTG (Fig. 1A) . Quantification by densitometric analysis of three separate blots confirmed this finding (Fig. 1B) . Saturation binding analysis using [ 3 H]quisqualate indicated that, at 100 M IPTG, 186 Ϯ 12 fmol was induced per milligram of protein (approximately 25,000 receptors per cell) and, at 10 M IPTG, 136 Ϯ 12 fmol/mg of protein was induced. The receptor density induced by the two IPTG concentrations was statistically different (t test, p Ͻ 0.05) and equates to an increase of ϳ40% between 10 and 100 M IPTG.
The expression of mGluR5a protein was also accompanied by an increase in quisqualate-induced total 
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InsPs accumulation, but importantly this effect was lost in cells chronically treated with PDBu. The increase in the quisqualate response by PDBu treatment overnight likely results from the absence of agonist-stimulated feedback inhibition by PKC, reflecting the dynamic desensitization mechanism discussed below. These data clearly demonstrate the acute sensitivity of mGluR5a to potential agonist-induced feedback regulation by PKC. mGluR5a-induced InsP 3 and Ca 2ϩ Oscillations-Oscillatory patterns of Ca 2ϩ i responses were detected in Fura-2AM-loaded CHO-lac-mGlu5a cells pre-treated with 100 M IPTG and challenged with maximal concentrations of glutamate (100 M) ( Fig. 2A) . Similar patterns were observed in response to the mGluR agonists, quisqualate and (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (ACPD) (not shown). Inclusion of the selective mGluR5 non-competitive antagonist; 2-methyl-6-(phenylethynyl)pyridine (MPEP), at 500 nM completely abolished the glutamate (100 M)-induced Ca i oscillations by visualizing repetitive translocation to the cytosol of eGFP-PH PLC␦ in Fura-2AM-loaded cells (9) . This "InsP 3 -biosensor" initially binds to the InsP 3 head-group of phosphatidylinositol 4,5-bisphosphate (PtdInsP 2 ) but translocates to the cytosol following activation of PLC due to its greater affinity for the soluble form of InsP 3 (24 -26) . Here we show that challenge with 100 M glutamate similarly induces oscillations in InsP 3 levels in the CHO-lacmGlu5a cells and that these are abolished by an acute pretreatment with PDBu ( Fig. 2D ). Despite convincing evidence to the contrary (25) (26) (27) , it has been argued that the eGFP-PH PLC␦ probe selectively detects the fall in PtdInsP 2 in N1E-115 cells rather than the increase in InsP 3 (28). Because different temporal patterns of PtdInsP 2 and InsP 3 metabolism may occur (29) , which could influence our interpretation of InsP 3 -controlled Ca 2ϩ i release, it was important to confirm "sensing" of InsP 3 by the eGFP-PH PLC␦ fusion protein.
CHO-lac-mGlu1␣ cells were co-transfected with eGFP-PH PLC␦ (0.5 g of DNA) in combination with either a truncated InsP 3 3-kinase or kinase-dead version tagged with DsRed2 (1 g of DNA). The eGFP-PH PLC␦ fusion protein became enriched over the plasma membrane through its association with PtdInsP 2 , whereas the truncated DsRed2-InsP 3 3-kinase, lacking the F-actin binding domain (18) , localized to the cytosol (Fig. 2E,  inset) . Cells expressing the kinase-dead protein showed a peak and plateau in eGFP-PH PLC␦ translocation to the cytosol following challenge with 100 M glutamate (Fig. 2E) . In contrast, expression of the kinase-active form resulted in little or no translocation of eGFP-PH PLC␦ (Fig. 2E) . The mean data from around 60 cells (Fig. 2F ) clearly indicate that, in the absence of increases in InsP 3 , eGFP-PH PLC␦ failed to translocate. Experiments testing the effect of co-transfection of CHO-lac-mGlu1␣ and -mGlu5a cells with full-length InsP 3 3-kinase, or vector control, on eGFP-PH PLC␦ sub-cellular distribution similarly indicated that increases in InsP 3 are required to initiate translocation (not shown). These data indicate that, at least for these receptors and this cell system, the translocation of eGFP-PH PLC␦ is predominantly a consequence of increases in InsP 3 rather depletion of PtdInsP 2 levels.
Dynamic Desensitization of mGluR5a-Dual imaging of Ca 2ϩ
i and InsP 3 demonstrated not only that both messengers oscillate concurrently but also that they are dependent upon PKC activity, because inclusion of 1 M staurosporine converted these oscillations to a peak and elevated plateau response (Fig. 3A) . Following an overnight incubation of cells with 1 M PDBu to down-regulate PKCs, the oscillatory Ca 2ϩ i
and InsP 3 signals were also converted to a peak and sustained plateau response (Fig. 3B ). This treatment strategy successfully attenuates PKC activity, because, after washing the cells for ϳ1 h and then challenging acutely with 1 M PDBu, no effect on InsP 3 production was observed (Fig. 3C ), which contrasts with the data in Fig. 2D for non-PKC down-regulated CHO-lac-mGlu5a cells. The conversion from oscillatory to a sustained InsP 3 production following chronic PDBu treatment also provides an explanation of the enhanced quisqualate-induced [ 3 H]InsPs accumulation detected in Fig. 1F . To demonstrate that the feedback regulation by PKC is a dynamic process, the effect of inclusion of the protein phosphatase 1/2A inhibitor, calyculin A (100 nM), during the quisqualate challenge was determined. Pre-treatment with calyculin A reduced the frequency of the mGluR5a-induced Ca 2ϩ i oscillations ( Fig. 3D) indicating that reactivation of receptor signaling by protein phosphatase 1/2A activity is critical to the continuation of the response. The initial peak height following calyculin A treatment was 91 Ϯ 7% of that in the absence of the protein phosphatase inhibitor, suggesting that this alone was unlikely to be the cause of the dramatic change in frequency. Similar experiments to test the effect of phosphatase inhibition on InsP 3 oscillations were hampered by cell-shape changes, which likely result from the action of calyculin A on the actin cytoskeleton (30) .
The dynamic nature of the process was also indicated by the visualization of oscillatory translocation of PKC␥ tagged with eGFP. CHO-lac-mGlu5a cells transiently transfected with PKC␥-eGFP showed exclusive cytosolic expression of the fusion protein under basal conditions (Fig. 3E, inset) . Challenge with 100 M glutamate caused redistribution to the plasma membrane (Fig. 3E, inset ) and oscillatory changes in the level of cytosolic fluorescence were found to occur with time. Two examples are provided of either high (Fig. 3E) or low (Fig. 3F ) frequency oscillations induced by glutamate exposure. Because the membrane association of PKC is generally accepted to indicate its activation (31), the sinusoidal oscillations detected during the agonist challenge likely represent the cyclical inactivation/reactivation of a proportion of the total PKC. Importantly, expression of PKC␥-eGFP had no apparent effect on glutamate-evoked Ca 2ϩ i oscillations (data not shown). These findings mirror those in the study by Codazzi et al. (11) using eGFP-tagged PKC␥ in hippocampal astrocytes.
The combined data provide strong evidence for a dynamic desensitization mechanism underlying mGluR5a-induced Ca o , oscillatory InsP 3 responses reverted to a peak and sustained phase (Fig. 4A) . Indeed, the peak and plateau of the InsP 3 production was enhanced relative to the height of the initial and subsequent oscillations, respectively (Fig. 4B) 
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ing glutamate as the agonist (data not shown). The sustained agonist-evoked responses were reduced in thapsigargin-treated cells in buffer containing 1.3 mM compared with nominally Ca 2ϩ -free conditions (Fig. 4, C and D) . Taken together these data suggest that the net effect of increases in [Ca 2ϩ ] i is inhibitory and so InsP 3 oscillations are unlikely to occur secondarily to Ca 2ϩ i release. However, the fluctuations in [Ca 2ϩ ] i are an absolute requirement to inhibit InsP 3 production, presumably through activation of classic PKC, and hence facilitate an oscillatory response.
Earlier work identified mGluR5 as a target for PKC-mediated phosphorylation and desensitization (13, 14, 34) , and so the receptor represents a likely site of action for activated Ca 2ϩ -dependent PKCs. However, some PLC-␤ isoforms (35), G proteins (36) , and RGS proteins (12) are also regulated by PKC and/or Ca 2ϩ , and the generation of InsP 3 oscillations could arise through a combination of inhibitory effects on these constituents of the PLC signaling complex. It is also important to note that, irrespective of the target for feedback inhibition, the oscillations in Ca 2ϩ i result from a dynamic on/off switch in mGluR5a activity with the fluctuations in InsP 3 levels fundamental to continuation of the response. Thus, InsP 3 levels oscillate in a manner that is not secondary to Ca 2ϩ i release, the PKC␥ biosensor shows oscillatory activation and in the absence of phosphatase activity oscillations are lost. Moreover, comparison with earlier experiments on mGluR1␣ (26, 37) and CHOlac-mGlu5a cells chronically challenged with PDBu (9) reveals that mGluR5a can stimulate InsP 3 production to levels that, in 
the absence of feedback regulation, would cause sustained Ca 2ϩ i release. In this regard our data differ from work on, for example, cholecystokinin receptors in pancreatic acinar cells (38) where Ca 2ϩ i regulates its own release in the absence of feedback control over InsP 3 production, likely through a regenerative CICR-like mechanism.
Receptor Density Not Agonist Concentration Determines Oscillation Frequency-The frequency of the Ca 2ϩ i oscillations was found to be insensitive to changes in the agonist concentration across a broad range as illustrated by the representative traces in Fig. 5A . This insensitivity was observed for CHOlac-mGlu5a cells induced with a range of different IPTG concentrations (Fig. 5B ) and was mirrored in the frequency of quisqualate-induced InsP 3 oscillations (Fig. 5C) . Moreover, the number of InsP 3 spikes induced by three different agonists, the full agonists glutamate and quisqualate and the partial agonist ACPD, was essentially the same in each individual cell despite the fact that the initial amplitude induced by ACPD was smaller than for the full agonists (Fig. 5, D and E) . These findings are more consistent with dynamic PKC feedback inhibition, rather than regenerative CICR, underlying mGluR5a- To determine whether receptor density, rather than agonist concentration, affected the oscillation frequency, CHO-lacmGlu5a cells were induced with various amounts of IPTG. As illustrated in Fig. 5B , although this had little effect on the agonist sensitivity of the mGluR5a-stimulated Ca 
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ceptor expression (Fig. 6A) . Similarly the initial peak [Ca 2ϩ ] i was dependent upon the [IPTG] used to induce mGluR5a expression with the half-maximal effect observed at ϳ5 M (Fig.  6B) . Importantly, the levels of mGluR5a expression significantly influenced the distribution of the oscillation frequency within the population (Fig. 6C) . At high concentrations of IPTG, the vast majority of cells responded to 100 M glutamate with greater than 10 spikes/4 min, but the predominant fre- 
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quency decreased dramatically as [IPTG] reduced. The data are summarized in Fig. 6D , which shows the mean data for each of the concentrations of IPTG used to induce receptor expression.
Representative traces for the response in cells expressing different levels of receptor are provided in Fig. 6E . Additional evidence that functional receptor density modulates the oscillation frequency was obtained using MPEP, because this non-competitive antagonist inhibits mGluR5 in an agonist concentration-independent fashion (39) and so effectively mimics receptor density changes by decreasing the number of activated receptors. Fig. 7 shows the effect of various concentrations of MPEP (1-100 nM) on the pattern of Ca (Fig. 7A) . The same data represented as a percentage change relative to the control number of oscillations are shown in Fig. 7B , together with the change in the peak height of the initial Ca 2ϩ i spike. Fig. 7C provides representative traces (from between 68 and 118 separate cells) for the effect of four different concentrations of MPEP. The combined data from the experiments using the LacSwitch to control receptor expression (Fig. 6 ) and MPEP to reduce the number of activated receptors (Fig. 7) clearly demonstrate the importance of mGluR5a density in determining the resultant Ca Determinants of Ca 2ϩ Oscillation Frequency 35956 those described here. In our previous work (9) we found that down-regulation of PKC by overnight PDBu treatment abolished InsP 3 oscillations across the entire concentration range. At maximal concentrations of agonist, this resulted in a conversion of the oscillatory Ca 2ϩ i responses to a peak and plateau (Fig. 8A) . Importantly, fluctuations in Ca 2ϩ i still occurred following challenge with low concentrations of agonist (Fig. 8B) . The frequency of these oscillations was found to be lower than that observed in control CHO-lac-mGlu5a cells and was also sensitive to the agonist concentration, with few oscillations evident at low glutamate concentrations, through to sustained peak and plateau elevations in [Ca 2ϩ ] i at high agonist concentrations. At 1 M glutamate a range of different patterns of Ca 2ϩ i was observed, which showed remarkable similarity to those reported for CICR-mediated Ca 2ϩ i release in HeLa cells following challenge with histamine ( Fig. 8C (40) ). In addition to repetitive baseline spiking there were cells that initially responded with a peak and sustained plateau, which reverted to baseline spiking (Fig. 8C) . The combined data lead to the conclusion that a single receptor is able to stimulate Ca 2ϩ i oscillations via two distinct mechanisms dependent upon the extent of the dynamic desensitization.
DISCUSSION
Our recent work has provided crucial evidence that Ca 2ϩ i oscillations are accompanied by InsP 3 oscillations in single cells expressing mGluR5a (9) . Moreover, the results presented here strongly support a PKC-dependent "dynamic desensitization" model whereby PKC can phosphorylate the receptor initiating cycles of activation/deactivation as first suggested by Kawabata et al. (13, 14) . The decisive evidence is the observation that increases in [Ca 2ϩ ] i are an absolute requirement for InsP 3 oscillations to occur (Fig. 4) . Because the responses in the absence of Ca 2ϩ are greater than in its presence, it seems probable that released Ca 2ϩ and/or Ca 2ϩ influx is activating a classic Ca 2ϩ -and diacylglycerol-dependent PKC that then exerts feedback inhibition on InsP 3 production. Importantly PKC␥ was shown to oscillate confirming data reported previ- levels consequently fall and PKC activity is no longer sustained, and 5) dephosphorylation involving protein phosphatases 1 and/or 2A resets the system to allow InsP 3 production to recommence.
The present work reveals that the oscillation frequencies of mGluR5a-stimulated Ca 2ϩ i responses, which involve this dynamic desensitization mechanism, are not determined by changes in the agonist concentration. In this regard mGluR5a resembles the M 3 muscarinic receptor-induced Ca 2ϩ i oscillations in lacrimal acinar cells (16) , which were also dependent on PKC feedback. Because the Ca 2ϩ i oscillation frequency is a crucial variable in determining the cellular response (e.g. Refs. 5 and 6), the challenge here has been to identify what determines the frequency in mGluR5 signaling.
Having established that mGluR5a-induced Ca 2ϩ i oscillations involve PKC-mediated feedback inhibition, probably at the level of the receptor, it seemed conceivable that changes in the expression levels of the target protein could influence the oscillation frequency by changing the rates of phosphorylation and dephosphorylation. Thus, the rate of recovery of an activated state by dephosphorylation would, from simple Michaelis-Menten kinetics, be enhanced as the substrate concentration increased. Kawabata et al. (13, 14) previously provided convincing evidence that PKC phosphorylation of a single threonine residue (Thr-840) in the C-terminal tail of mGluR5 is responsible for its oscillatory behavior, and numerous other PKC-sensitive sites have been identified throughout the cytosolic domains of the receptor (34) . We therefore chose to determine whether mGluR5a expression levels could determine the oscillation frequency and, using an inducible expression system and a non-competitive receptor antagonist, demonstrate that receptor density does indeed change the oscillation frequency. The agonist dependence of Ca release to a sustained peak and plateau. Some of these observations, as well as those of others (11, 13, 14) , are apparently in contradiction with the findings recently reported by Dale et al. (42) where, although repetitive translocation of PKC was observed for mGluR5a in HEK293 cells, no role in feedback regulation could be identified for PKC. In fact their proposed model contrasted markedly with the conclusions drawn by Codazzi et al. (11) from similar studies on mGluR5a in astrocytes. There are, however, important differences between the characteristics of the Ca 2ϩ i oscillations observed by Dale et al. (42) and those described by others (9, 13, 14) . First, the frequency of the mGluR5a-induced Ca 2ϩ i oscillations reported by Dale et al. (42) is low (40 s/oscillation versus ϳ15 s/oscillation reported here; Fig. 6D ). Second, high concentrations of quisqualate (100 M) were used to elicit a response when this agonist should maximally activate mGluRs in the low micromolar range. Finally, despite the use of this supramaximal agonist concentration, mGluR1␣ was found to exclusively induce Ca 2ϩ i oscillations (42) rather than sustained responses that predominate in other reports (e.g. Refs. 9, 14, and 37, and Fig. 2E ). In combination, these findings suggest that, in the transiently expressed heterologous HEK293 cell system used by Dale et al. (42) , mGluRs may couple poorly to effector systems, not initiate PKC feedback inhibition, and elicit Ca increases in the absence of adequate feedback inhibition leads us to propose a model (Fig. 9 ) that may prove broadly applicable to other receptors. Moreover, it can perhaps be used to explain the divergent findings within the literature. We suggest that the different Ca 2ϩ i signals identified above are actually a continuum of response with the extent of negative feedback determining how broad a period of dynamic desensitization exists between the extremes of regenerative CICR and a saturation of the Ca 2ϩ i release mechanisms. In this model, at low concentrations of agonist or when coupling to PLC activity is poor, the amount of InsP 3 produced would only be sufficient to sensitize the InsP 3 receptors to CICR. As the stimulus strength increases, enough InsP 3 is produced to cause widespread release of Ca i release controlled by dynamic uncoupling. Importantly, from the work described here for mGluR5a and previously for the muscarinic receptor (16), it appears that the different oscillatory patterns of Ca 2ϩ i signaling possess distinct characteristics: for regenerative CICR the oscillation frequency is determined by the agonist concentration, whereas for dynamic uncoupling it may be primarily controlled by the receptor density and be insensitive to the level of stimulus strength.
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switch the GPCR-G protein-PLC signaling system off, InsP 3 production would fluctuate and Ca 2ϩ i levels continue to oscillate until sufficient InsP 3 "leaks" through to cause a sustained opening of the Ca 2ϩ i release channels. This model accommodates the inhibitory role of PKC identified here and other negative feedback loops such as that recently reported for RGS4 in the generation of Ca 2ϩ i oscillations (12) , which could function in combination or isolation.
Because mGluR5 is particularly sensitive to PKC-induced inhibition (Figs. 1 and 2 ) (34) the transition period of dynamic uncoupling appears to be very broad for this particular GPCR. However, the ability to completely switch off mGluR5 signaling is dependent upon a number of criteria, including the balance between PKC and phosphatase activity, receptor density, and coupling efficiency to effector systems. If, PKC activity was relatively low, the transition between regenerative CICR-induced Ca 2ϩ i oscillations and sustained Ca 2ϩ i release could be shorter. Our model would therefore explain the reported differences (11, 41, 42) in mGluR5 signaling by arguing that in different cell systems such factors vary, and consequently the extent of the different types of Ca 2ϩ i signal (oscillatory and sustained) changes, i.e. the positions of the two sliders move.
For other GPCRs that are less sensitive to feedback inhibition or strongly stimulate PLC activity, the period of dynamic uncoupling will be shorter or possibly absent. Of particular relevance in this regard are the observations of M 3 muscarinic receptor signaling in lacrimal acinar cells (16) . In these cells agonist concentration-insensitive Ca 2ϩ i oscillations occur via PKC feedback inhibition but across a relatively restricted concentration range. At high doses of agonist the oscillations are lost and Ca 2ϩ i release becomes sustained. Accordingly, in our model the two sliders would be positioned such that across the continuum the period of dynamic desensitization would be reduced and that of sustained Ca 2ϩ i release increased compared with mGluR5. Importantly, M 3 muscarinic receptors in other systems predominately evoke saturating responses (43) or oscillations with features characteristic of regenerative CICR (9), suggesting that, as for mGluR5, cell background is critical. Finally, an intriguing observation we have made with the InsP 3 biosensor is the high dependence of translocation upon the incubation temperature; this supports earlier findings that InsP 3 production is a temperature-sensitive process (e.g. 40) . Because many studies on Ca 2ϩ i oscillations are performed at room temperature rather than 37°C (used here) it is possible that this favors the observation of a regenerative CICR mechanism. It will be interesting to determine whether, at physiological temperatures, any of the classic systems used to study CICR also have a period of dynamic desensitization prior to signal saturation.
Physiological Implications for mGluR5 Signaling-It is generally accepted that the information content of Ca 2ϩ i oscillations is frequency encoded, such that changes in the time between spikes can differentially influence Ca 2ϩ -dependent enzymes and cellular processes like gene transcription (5, 6) . Two key points from our observations could have physiologically important consequences. The first is that, in instances where receptor density is the predominant control over the oscillation frequency, the regulation of receptor trafficking to and from the plasma membrane is critical. The second is that agonist concentration-dependent control over oscillation frequency can be restored in situations where feedback inhibition is insufficient to turn off receptor signaling. Under these circumstances the activity or expression patterns of protein kinases and phosphatases, in addition to changes in the coupling efficiency of the receptor to G proteins and PLCs, is important. Selective regulation of these components might allow sustained Ca 2ϩ i responses to be elicited and a return to low frequency agonist-concentration sensitive Ca 2ϩ i oscillations. The cellular distribution of Group I mGluRs within neurones is a tightly regulated process involving adaptor molecules of the Homer protein family (reviewed in Refs. 15, 44, and 45), which control axonal/dendritic targeting of the receptors, direct spatial orientation of mGluRs within the post-synaptic density, and mediate cross-linking to other post-synaptic density constituents (46 -48) . Homer proteins also influence mGluR clustering and intracellular trafficking to change the local density and cell surface expression of the receptor (e.g. Refs. 49 -52) . Moreover, activation of mGluR5 increases the lateral mobility of the receptor in hippocampal neurones, whereas expression of Homer proteins acts to decrease diffusion and retain receptor in a clustered state (52) . In view of this it is interesting to note that significant amounts (70 -80%) of mGluR5 have been reported to be located in non-synaptic sites in hippocampal pyramidal neurones (53) and associated with the endoplasmic reticulum of the substantia nigral parallel fibers (54) . Because these extrasynaptic pools of mGluR5 are not apposed to the location of glutamate release, they might represent trafficked receptors that can readily redistribute to and from synaptic sites to provide a means of influencing mGluR5-induced responses. Finally, these effects of Homers can be dynamically regulated by the "dominant-negative" Homer-1a, which is rapidly expressed in response to various neuronal stimuli (45) and has been directly shown to influence mGluR cell-surface expression (49, 55) . Moreover, the synaptic distribution of Homer-1c is dynamically controlled by neuronal activity (56) . Influencing the mGluR5a-induced Ca 2ϩ i oscillation frequency by Homer-controlled mGluR5 expression may thus provide a novel means for controlling the physiological role of mGluR5a and this possibility is currently under investigation.
Conclusions-The key observation of the current work has been that receptor density is a crucial factor in controlling the Ca 2ϩ i oscillation frequency following activation of the metabotropic glutamate receptor, mGluR5a. This receptor elicits intracellular Ca 2ϩ i oscillations through a PKC-dependent negative feedback on receptor-induced InsP 3 production, which is largely unaffected by changes in the agonist concentration. In the absence of this feedback regulation, however, Ca 2ϩ i oscillations still occur at low agonist concentration, but by an apparently separate mechanism. The two types of oscillation have a distinct means of controlling the pattern and frequency of Ca 2ϩ i release: receptor density being most important for dynamic uncoupling, but agonist concentration important for classic regenerative CICR. This leads us to propose a "slidingscale" model where the extent of feedback inhibition ultimately determines the propensity of a particular GPCR to elicit InsP 3 and hence Ca 2ϩ i oscillations through a dynamic desensitization mechanism.
